Cell No. : Cell Name
RCB2860 : MRMT-1
update : 2024/11/08
|
| Comment | Rat cell line derived from mammary carcinoma. TKG0132 (Deposited from Tohoku Univ.). |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Fukuda, Hiroshi
|
| Year of deposit |
2008
|
| Original cell |
TKG0132
|
| Animal |
_rat
< Mammals
|
| Strain name |
SD
|
| Gender |
Female
|
| Tissue |
mammary gland
|
| Disease name |
mammary carcinoma
|
| Classification |
cancer
|
| History |
Cell Resource Center for Biomedical Research, Tohoku University（TKG0132）
|
|
Lifespan |
infinite
|
| Morphology |
other
|
| Cellosaurus(Expasy) |
CVCL_5156
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
RPMI1640 + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture or Medium Renewal : once/2-3 days
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| Animal PCR |
|
OK
|
| Isozyme |
|
LD, NP, AST
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
3
|
| User's Publication |
13
|
| User's Publication |
|
22167
Okuda T.
Characterization of antibodies induced by immunization of mice with isoglobotrihexosylceramide (iGb3).
Biochem Biophys Rep
2024
40:101855
PubMed ID: 39552707
DOI: 10.1016/j.bbrep.2024.101855
|
|
19994
Jerard C, Madhusudanan P, Swamy A, Ravikumar K, Shankarappa SA.
Secretome mediated interactions between sensory neurons and breast cancer cells
Int J Cancer
2023
153(2):427-436
PubMed ID: 37067100
DOI: 10.1002/ijc.34529
|
|
12523
Kucharczyk MW, Chisholm KI, Denk F, Dickenson AH, Bannister K, McMahon SB.
The impact of bone cancer on the peripheral encoding of mechanical pressure stimuli
Pain
2020
161(8):1894-1905
PubMed ID: 32701848
DOI: 10.1097/j.pain.0000000000001880
|
|
11353
Falk S, Appel CK, Bennedbæk HB, Al-Dihaissy T, Unger A, Dinkel K, Heegaard AM.
Chronic high dose P2X7 receptor inhibition exacerbates cancer-induced bone pain.
Eur. J. Pharmacol.
2019
PubMed ID: 30582910
DOI: 10.1016/j.ejphar.2018.12.032
|
|
10314
Oka S, Kanagawa M, Doi Y, Schuster DM, Goodman MM, Yoshimura H.
PET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models.
Theranostics
2017
7:2048-2064
PubMed ID: 28656060
DOI: 10.7150/thno.19883
|
|
14754
Oka S, Kanagawa M, Doi Y, Schuster DM, Goodman MM, Yoshimura H.
Fasting Enhances the Contrast of Bone Metastatic Lesions in 18 F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases
Int J Mol Sci
2017
18(5):934
PubMed ID: 28468238
DOI: 10.3390/ijms18050934
|
|
14584
Effects of Src-kinase inhibition in cancer-induced bone pain
Effects of Src-kinase inhibition in cancer-induced bone pain
Mol Pain
2016
12:1744806916643725
PubMed ID: 27094550
DOI: 10.1177/1744806916643725
|
|
7478
Falk S, Schwab SD, Frosig-Jorgensen M, Clausen RP, Dickenson AH, Heegaard AM.
P2X7 receptor-mediated analgesia in cancer-induced bone pain.
Neuroscience
2015
291:93-105
PubMed ID: 25686524
DOI: 10.1016/j.neuroscience.2015.02.011
|
|
5361
Falk S, Patel R, Heegaard A, Mercadante S, Dickenson AH.
Spinal neuronal correlates of tapentadol analgesia in cancer pain: a back-translational approach.
Eur J Pain
2015
19(2):152-8
PubMed ID: 24917026
DOI: 10.1002/ejp.530
|
|
5362
Falk S, Ipsen DH, Appel CK, Ugarak A, Durup D, Dickenson AH, Heegaard AM.
Randall Selitto pressure algometry for assessment of bone-related pain in rats.
Eur J Pain
2015
19(3):305-12
PubMed ID: 25057115
DOI: 10.1002/ejp.547
|
|
5363
Varani K, Vincenzi F, Targa M, Paradiso B, Parrilli A, Fini M, Lanza G, Borea PA.
The stimulation of A(3) adenosine receptors reduces bone-residing breast cancer in a rat preclinical model.
Eur J Cancer
2013
49(2):482-91
PubMed ID: 22770890
DOI: 10.1016/j.ejca.2012.06.005
|
|
5364
Fini M, Salamanna F, Parrilli A, Martini L, Cadossi M, Maglio M, Borsari V.
Electrochemotherapy is effective in the treatment of rat bone metastases.
Clin Exp Metastasis
2013
30(8):1033-45
PubMed ID: 23832763
DOI: 10.1007/s10585-013-9601-x
|
|
5365
Vincenzi F, Targa M, Corciulo C, Tabrizi MA, Merighi S, Gessi S, Saponaro G, Baraldi PG, Borea PA, Varani K.
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
Pain
2013
154(6):864-73
PubMed ID: 23518609
DOI: 10.1016/j.pain.2013.02.007
|
Back
Top
CELL BANK Website
